Cargando…
COVIDOUTCOME—estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome
Numerous studies demonstrate frequent mutations in the genome of SARS-CoV-2. Our goal was to statistically link mutations to severe disease outcome. We used an automated machine learning approach where 1594 viral genomes with available clinical follow-up data were used as the training set (797 ‘seve...
Autores principales: | Nagy, Ádám, Ligeti, Balázs, Szebeni, János, Pongor, Sándor, Győrffy, Balázs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106440/ https://www.ncbi.nlm.nih.gov/pubmed/33963845 http://dx.doi.org/10.1093/database/baab020 |
Ejemplares similares
-
Different mutations in SARS-CoV-2 associate with severe and mild outcome
por: Nagy, Ádám, et al.
Publicado: (2021) -
KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
por: Nagy, Ádám, et al.
Publicado: (2016) -
A Network-Based Target Overlap Score for Characterizing Drug Combinations: High Correlation with Cancer Clinical Trial Results
por: Ligeti, Balázs, et al.
Publicado: (2015) -
Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer
por: Menyhárt, Otília, et al.
Publicado: (2019) -
Differential signal sensitivities can contribute to the stability of multispecies bacterial communities
por: Juhász, János, et al.
Publicado: (2017)